Brain surgery delivers gene therapy in bid to protect Parkinson's patients
NCT ID NCT01621581
Summary
This study tested the safety of a new gene therapy for advanced Parkinson's disease. Researchers used a special surgical technique to deliver a gene (AAV2-GDNF) directly into the brain. The goal was to see if this gene could help produce a protective protein to support the brain cells damaged by Parkinson's. The study involved 25 participants and followed them for up to 5 years.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON'S DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
Conditions
Explore the condition pages connected to this study.